denovoMATRIX logo — Enabling biology in vitro

denovoMATRIX

Enabling biology in vitro

Founded 2018 Germany Dresden, Germany 7 employees Seed Biotechnology, Health and Wellness +2

General Information

Company Name denovoMATRIX
Founded Year 2018
Location Germany Dresden, Germany
Employees 7
Industries Biotechnology, Health and Wellness, Life Sciences +1
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with denovoMATRIX. To contact denovoMATRIX, visit denovomatrix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does denovoMATRIX compare?

A PDF of denovoMATRIX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting denovoMATRIX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About denovoMATRIX

denovoMATRIX is a German biotechnology startup founded in 2018, with the slogan "Enabling biology in vitro." The company's primary focus is on offering a combinatorial screening matrix product for life science researchers. This product enables researchers to identify the best tailor-made biomaterials for their specific cell types, individual research questions, and potential future medical applications.

The startup successfully secured a Seed Round investment on 13 December 2018, with participation from High-Tech Gründerfonds and TGFS - Technologiegründerfonds Sachsen.

With its innovative approach to addressing the needs of life science researchers, denovoMATRIX is poised to make significant strides in the biotechnology sector. The company's ability to offer customized solutions to a burgeoning market showcases its potential for sustained growth and impact within the industry.

Business keywords: biotech, combinatorial screening, biomaterials, cell-based therapies, clean meat industry, cell culture, life sciences, medical applications

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 2
TGFS - Technologiegründerfonds Sachsen, HTGF | High-Tech Gruenderfonds
13 Dec 2018

denovoMATRIX Alternatives & Competitors

View All Alternatives
denovoMATRIX vs
Uncommon
Uncommon United Kingdom

We’re using ground-breaking cell technologies to revolutionise global food production - starting wit...

Series A
58 employees
Biotechnology, Food and Beverage
denovoMATRIX vs

Discovery with Human touch

Non Equity Assistance
4 employees
Biotechnology, Health Care
denovoMATRIX vs
Altis Biosystems
Altis Biosystems United States

Capturing the Complexity of the Human Gut

Series A
28 employees
Biotechnology, Health Care

FAQ About denovoMATRIX

Enabling biology in vitro
denovoMATRIX was founded in 2018.
denovoMATRIX is headquartered in Dresden, Germany.
denovoMATRIX operates in Biotechnology, Health and Wellness, Life Sciences and AgriTech. Its work centres on biotech, combinatorial screening, biomaterials and cell-based therapies.
denovoMATRIX has approximately 7 employees.
denovoMATRIX has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to denovoMATRIX include Uncommon, InvivoSciences® Inc., Altis Biosystems, BioTrove, SmartCella Holding AB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
denovoMATRIX and Uncommon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for denovoMATRIX, https://bouncewatch.com/company/denovomatrix, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes